Describes the core clinical features of Corticobasal Degeneration (CBD) and its
relationships to progressive supranuclear palsy (PSP) and frontotemporal dementia (FTD) …

The accuracy of the clinical diagnosis of corticobasal degeneration (CBD) is unknown. To
determine its diagnostic accuracy, we presented 105 cases with known neuropathologic …

Objective: To devise a short bedside cognitive and behavioral battery to assess frontal lobe
functions. Methods: The designed battery consists of six subtests exploring the following …

Objective: To compare the power of tests assessing different cognitive domains for the
identification of prodromal Alzheimer disease (AD) among patients with mild cognitive …

Confrontation naming is impaired in neurodegenerative conditions like Alzheimer's disease
(AD), frontotemporal dementia (FTD) and corticobasal degeneration (CBD). Some …

Objective: To provide evidence for the hypothesis that the corticobasal degeneration
syndrome (CBDs) overlaps significantly with primary progressive aphasia and …

Progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS; the most common
phenotype of corticobasal degeneration) are tauopathies with a relentless course, usually …

Corticobasal syndrome (CBS) and progressive supranuclear palsy (PSP) represent
challenging neurodegenerative disorders for clinicians and nonclinical scientists alike …

The presence of tau‐positive glial inclusions has been recently found a consistent feature in
the brains of patients with progressive supranuclear palsy (PSP), corticobasal degeneration …

Genetic mutations in the tau gene on chromosome 17 are known to cause frontotemporal
dementias. We have identified a novel silent mutation (S305S) in the tau gene in a subject …